Plain-English translation of NCT04388124 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called to see if it can help people with resistant hypertension—a type of high blood pressure that doesn't respond well to standard blood pressure drugs. Beyond just lowering blood pressure numbers, researchers want to know if this medication can also improve how your blood vessels work. The study will compare to a placebo (a dummy pill) over 8 weeks.
Resistant high blood pressure is particularly dangerous and hard to treat, putting patients at very high risk for heart problems. This medication might work differently than standard blood pressure drugs and could not only lower blood pressure but also help blood vessels function better.
You likely qualify if…
You likely don't qualify if…
You would take capsules by mouth twice daily for 8 weeks—either the study medication or placebo. The dose starts low for the first 4 weeks, then increases for the final 4 weeks. During the trial, you'll have blood tests and measurements of your blood pressure and blood vessel function to see how the medication affects your body. Researchers will pay special attention to ensuring the medication is safe for your kidneys and liver.
AI-generated summary from trial data · Sep 5, 2026 · Not medical advice
France